A Randomized, Double-blind, Placebo-controlled, Forced Titration, Dose-ranging Study of AR08 in the Treatment of Vasomotor Symptoms (VMS) in Menopausal Females: A Proof-of-Concept Study

Trial Profile

A Randomized, Double-blind, Placebo-controlled, Forced Titration, Dose-ranging Study of AR08 in the Treatment of Vasomotor Symptoms (VMS) in Menopausal Females: A Proof-of-Concept Study

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Dec 2015

At a glance

  • Drugs AR 08 (Primary)
  • Indications Vasomotor symptoms
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Arbor Pharmaceuticals
  • Most Recent Events

    • 11 Feb 2015 Status changed from suspended to discontinued as reported by ClinicalTrials.gov record.
    • 11 Jun 2014 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 10 Feb 2014 Status changed from not yet recruiting to recruiting according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top